Efficacy and safety of switching from basal insulin to once‐daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4‐week, randomized, open‐label, treat‐to‐target study

AIMS/INTRODUCTION: A prospective, 4‐week, single‐center, randomized, open‐label, parallel‐group, treat‐to‐target study was carried out to develop an algorithm for safe and effective switching from basal insulin to once‐daily insulin degludec/insulin aspart (IDegAsp) in patients with inadequately con...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Yoshio, Nishine, Ami, Hashimoto, Eriko, Nakayama, Taiga, Sasaki, Yosuke, Murakami, Mariko, Ishii, Satoshi, Kato, Hiroyuki, Tanaka, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934257/
https://www.ncbi.nlm.nih.gov/pubmed/28921900
http://dx.doi.org/10.1111/jdi.12748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934257/
https://www.ncbi.nlm.nih.gov/pubmed/28921900
http://dx.doi.org/10.1111/jdi.12748

Ejemplares similares